The PEDro scale is a valid measure of the methodological quality of clinical trials: a demographic study

被引:1437
|
作者
de Morton, Natalie A. [1 ]
机构
[1] Monash Univ, Clayton, Vic 3800, Australia
来源
AUSTRALIAN JOURNAL OF PHYSIOTHERAPY | 2009年 / 55卷 / 02期
基金
澳大利亚国家健康与医学研究理事会;
关键词
Research design; Clinical trials; Data interpretation; statistical; PEDro scale; Quality assessment; Statistical models; Rasch analysis; RANDOMIZED CONTROLLED-TRIALS;
D O I
10.1016/S0004-9514(09)70043-1
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Questions: Does the PEDro scale measure only one construct ie, the methodological quality of clinical trials? What is the hierarchy of items of the PEDro scale from least to most adhered to? Is there any effect of year of publication of trials on item adherence? Are PEDro scale ordinal scores equivalent to interval data? Design: Rasch analysis of two independent samples of 100 clinical trials from the PEDro database scored using the PEDro scale. Results: Both samples of PEDro data showed fit to the Rasch model with no item misfit. The PEDro scale item hierarchy was the same in both samples, ranging from the most adhered to item random allocation, to the least adhered to item therapist blinding. There was no differential item functioning by year of publication. Original PEDro ordinal scores were highly correlated with transformed PEDro interval scores (r = 0.99). Conclusion: The PEDro scale is a valid measure of the methodological quality of clinical trials. It is valid to sum PEDro scale item scores to obtain a total score that can be treated as interval level measurement and subjected to parametric statistical analysis. [de Morton NA (2009) The PEDro scale is a valid measure of the methodological quality of clinical trials: a demographic study. Australian Journal of Physiotherapy 55: 129-133]
引用
收藏
页码:129 / 133
页数:5
相关论文
共 50 条
  • [1] The PEDro scale provides a more comprehensive measure of methodological quality than the Jadad Scale in stroke rehabilitation literature
    Bhogal, SK
    Teasell, RW
    Foley, NC
    Speechley, MR
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2005, 58 (07) : 668 - 673
  • [2] How to Classify Clinical Trials Using the PEDro Scale?
    Matos, Areolino Pena
    Pegorari, Maycon Sousa
    JOURNAL OF LASERS IN MEDICAL SCIENCES, 2020, 11 (01) : 1 - 2
  • [3] PEDro or Cochrane to Assess the Quality of Clinical Trials? A Meta-Epidemiological Study
    Armijo-Olivo, Susan
    da Costa, Bruno R.
    Cummings, Greta G.
    Ha, Christine
    Fuentes, Jorge
    Saltaji, Humam
    Egger, Matthias
    PLOS ONE, 2015, 10 (07):
  • [4] Reliability of the PEDro scale for rating quality of randomized controlled trials
    Maher, CG
    Sherrington, C
    Herbert, RD
    Moseley, AM
    Elkins, M
    PHYSICAL THERAPY, 2003, 83 (08): : 713 - 721
  • [5] Methodological quality of oncology noninferiority clinical trials
    Wayant, Cole
    Ross, Andrew
    Vassar, Matt
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 149
  • [6] Methodological quality of clinical trials of keloid scars
    Morales-Sanchez, Martha A.
    De Villafranca-Dugelby, Andrea
    Jurado-Santa Cruz, Fermin
    Peralta-Pedrero, Maria L.
    CIRUGIA Y CIRUJANOS, 2020, 88 (05): : 591 - +
  • [7] The PEDro scale had acceptably high convergent validity, construct validity, and interrater reliability in evaluating methodological quality of pharmaceutical trials
    Yamato, Tie Parma
    Maher, Chris
    Koes, Bart
    Moseley, Anne
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2017, 86 : 176 - 181
  • [8] Methodological quality and reporting of ethical requirements in clinical trials
    Ruiz-Canela, M
    de Irala-Estevez, J
    Martinez-González, MA
    Gómez-Gracia, E
    Fernández-Crehuet, J
    JOURNAL OF MEDICAL ETHICS, 2001, 27 (03) : 172 - 176
  • [9] Is time to joint replacement a valid outcome measure in clinical trials of drugs for osteoarthritis?
    Maillefert, JF
    Dougados, M
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2003, 29 (04) : 831 - +
  • [10] Quality of life as an outcome measure in cancer clinical trials
    Kiebert, GM
    EUROPEAN UROLOGY, 1997, 31 : 56 - 64